BioNTech SE Sponsored ADR
(NASDAQ: BNTX)

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

89.100 -

-0.450 (-0.50%)
价格区间 87.805 - 89.260   (1.66%)
开盘 89.260
昨收 89.550
买 89.010
买盘 34
卖 89.060
卖盘 21
成交量 792,563
成交额 49,327,320
注释 -
数据延迟。最后一次更新19 May 2026 03:51.
数据提供商
查看所有活动

Loading Chart...

Please login to view stock data and analysis